Meeder Asset Management Inc Ultragenyx Pharmaceutical Inc. Transaction History

Meeder Asset Management Inc

  • $1.58 Billion
  • Q1 2024

A detailed history of Meeder Asset Management Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 87 shares of RARE stock, worth $3,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Holding current value
$3,575
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$43.02 - $53.69 $3,742 - $4,671
87 New
87 $4,000
Q2 2022

Aug 08, 2022
SELL
$45.8 - $85.4 $6,824 - $12,724
-149 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$62.2 - $84.4 $72,027 - $97,735
-1,158 Reduced 88.6%
149 $11,000
Q4 2021

Feb 11, 2022
SELL
$73.71 - $87.86 $97,002 - $115,623
-1,316 Reduced 50.17%
1,307 $110,000
Q3 2021

Nov 08, 2021
BUY
$77.92 - $102.4 $73,478 - $96,563
943 Added 56.13%
2,623 $236,000
Q2 2021

Aug 09, 2021
SELL
$92.19 - $115.71 $27,564 - $34,597
-299 Reduced 15.11%
1,680 $160,000
Q1 2021

Apr 28, 2021
BUY
$106.9 - $167.73 $211,555 - $331,937
1,979 New
1,979 $225,000
Q4 2020

Feb 09, 2021
SELL
$84.4 - $177.39 $261,471 - $549,554
-3,098 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$72.98 - $90.0 $155,082 - $191,250
2,125 Added 218.4%
3,098 $254,000
Q2 2020

Aug 11, 2020
BUY
$46.91 - $78.22 $40,717 - $67,894
868 Added 826.67%
973 $77,000
Q1 2020

May 15, 2020
BUY
$33.8 - $62.9 $3,548 - $6,604
105 New
105 $5,000
Q4 2019

Feb 13, 2020
SELL
$36.08 - $45.83 $4,473 - $5,682
-124 Closed
0 $0
Q3 2019

Oct 17, 2019
BUY
$42.5 - $63.11 $5,270 - $7,825
124 New
124 $5,000
Q2 2019

Aug 05, 2019
SELL
$54.93 - $74.36 $32,848 - $44,467
-598 Closed
0 $0
Q1 2019

Apr 16, 2019
BUY
$39.87 - $69.36 $18,180 - $31,628
456 Added 321.13%
598 $41,000
Q4 2018

Jan 17, 2019
BUY
$38.89 - $77.3 $5,522 - $10,976
142 New
142 $6,000
Q1 2018

May 03, 2018
SELL
$44.33 - $58.52 $3,280 - $4,330
-74 Closed
0 $0
Q4 2017

Feb 02, 2018
BUY
$43.54 - $57.32 $3,221 - $4,241
74
74 $3,000

Others Institutions Holding RARE

# of Institutions
286
Shares Held
78.6M
Call Options Held
570K
Put Options Held
228K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.88B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email